Russell L Ellis, MD | |
1103 16th Ave Se, Decatur, AL 35601-3595 | |
(256) 350-0362 | |
Not Available |
Full Name | Russell L Ellis |
---|---|
Gender | Male |
Speciality | Physical Medicine And Rehabilitation |
Experience | 27 Years |
Location | 1103 16th Ave Se, Decatur, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134292766 | NPI | - | NPPES |
51507394 | Other | AL | BLUECROSS BLUESHIELD OF A |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | 00022020 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Decatur Morgan Hospital - Decatur Campus | Decatur, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Decatur Orthopaedic Clinic Llc | 5193742823 | 15 |
News Archive
Cardiovascular disease is the leading cause of death in patients with type 2 diabetes, and youth with severe obesity and type 2 diabetes face a high risk of developing cardiovascular disease during their lifetime.
When researchers evaluated consumers' understanding of allergy information on food labels, less than half of individuals found the information to be clear.
When President Barack Obama's health care reform was making its way through Congress, Republicans and other opponents registered plenty of criticisms: It was too generous, too inflexible and too centralized. But such concerns were brushed aside in the push to get a bill passed. Today, it's harder to ignore those flaws. Implementation of the program has brought tougher challenges than the administration led Americans to expect. So it has been obliged to make some major concessions to reality.
Scientists at Carnegie Mellon University's Molecular Biosensor and Imaging Center have developed new "fluorogen activating proteins" (FAPs) that will become a key component of novel molecular biosensor technology being created at Carnegie Mellon.
› Verified 5 days ago
Entity Name | Decatur Orthopaedic Clinic Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740331347 PECOS PAC ID: 5193742823 Enrollment ID: O20051101000312 |
News Archive
Cardiovascular disease is the leading cause of death in patients with type 2 diabetes, and youth with severe obesity and type 2 diabetes face a high risk of developing cardiovascular disease during their lifetime.
When researchers evaluated consumers' understanding of allergy information on food labels, less than half of individuals found the information to be clear.
When President Barack Obama's health care reform was making its way through Congress, Republicans and other opponents registered plenty of criticisms: It was too generous, too inflexible and too centralized. But such concerns were brushed aside in the push to get a bill passed. Today, it's harder to ignore those flaws. Implementation of the program has brought tougher challenges than the administration led Americans to expect. So it has been obliged to make some major concessions to reality.
Scientists at Carnegie Mellon University's Molecular Biosensor and Imaging Center have developed new "fluorogen activating proteins" (FAPs) that will become a key component of novel molecular biosensor technology being created at Carnegie Mellon.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Russell L Ellis, MD 1103 16th Ave Se, Decatur, AL 35601-3595 Ph: () - | Russell L Ellis, MD 1103 16th Ave Se, Decatur, AL 35601-3595 Ph: (256) 350-0362 |
News Archive
Cardiovascular disease is the leading cause of death in patients with type 2 diabetes, and youth with severe obesity and type 2 diabetes face a high risk of developing cardiovascular disease during their lifetime.
When researchers evaluated consumers' understanding of allergy information on food labels, less than half of individuals found the information to be clear.
When President Barack Obama's health care reform was making its way through Congress, Republicans and other opponents registered plenty of criticisms: It was too generous, too inflexible and too centralized. But such concerns were brushed aside in the push to get a bill passed. Today, it's harder to ignore those flaws. Implementation of the program has brought tougher challenges than the administration led Americans to expect. So it has been obliged to make some major concessions to reality.
Scientists at Carnegie Mellon University's Molecular Biosensor and Imaging Center have developed new "fluorogen activating proteins" (FAPs) that will become a key component of novel molecular biosensor technology being created at Carnegie Mellon.
› Verified 5 days ago
Mark Awoniyi, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2046 Beltline Rd Sw, Decatur, AL 35601 Phone: 256-604-0671 Fax: 256-353-0649 |